You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Corporate Information<br />
Internet Address:<br />
Corporate, product, financial and shareholder information,<br />
including news releases, financial filings and stock quotes are<br />
available at <strong>Bausch</strong> & <strong>Lomb</strong>’s web site:<br />
www.bausch.com<br />
Corporate Headquarters:<br />
One <strong>Bausch</strong> & <strong>Lomb</strong> Place<br />
Rochester, New York 14604<br />
(716) 338-6000<br />
(800) 344-8815<br />
News on Demand:<br />
<strong>Bausch</strong> & <strong>Lomb</strong>’s news releases are available toll-free by calling:<br />
(888) 329-1096<br />
Financial Literature:<br />
Copies of <strong>Bausch</strong> & <strong>Lomb</strong>’s annual reports and financial reports filed<br />
with the Securities and Exchange Commission, including its Form<br />
10-K, are available on our website, by mail (attn: Investor Relations)<br />
or by calling:<br />
(888) 884-8702<br />
(716) 338-5757<br />
Investor Relations:<br />
Security analysts and shareholders seeking information concerning<br />
company operations, shareholder programs or dividend policy<br />
may contact:<br />
Angela J. Panzarella<br />
Vice President, Investor Relations<br />
(716) 338-6025<br />
Angela_J_Panzarella@bausch.com<br />
Media Inquiries:<br />
News media representatives and others seeking general information<br />
may contact:<br />
Holly Houston<br />
Director, Media Relations<br />
(716) 338-8064<br />
Holly_Houston@bausch.com<br />
Transfer Agent:<br />
Shareholders seeking information regarding their individual accounts<br />
or dividend payments may contact our stock transfer agent:<br />
ChaseMellon Shareholder Services<br />
P.O. Box 3315<br />
South Hackensack, New Jersey 07606<br />
(800) 288-9541<br />
www.chasemellon.com<br />
Total recycled fiber content of not less than 50%<br />
Dividend Reinvestment Plan:<br />
The plan is available to all shareholders of <strong>Bausch</strong> & <strong>Lomb</strong> stock.<br />
Under the plan, shareholders may elect to have their cash dividends<br />
automatically invested in additional shares of the company’s common<br />
stock. Shareholders may also elect to make cash contributions of up<br />
to $60,000 per year to purchase additional shares. For additional<br />
information contact:<br />
Mellon Bank, N.A.<br />
Investment Services<br />
P.O. Box 3339<br />
South Hackensack, New Jersey 07606<br />
(800) 288-9541<br />
www.chasemellon.com<br />
Stock Listing:<br />
The common stock of the corporation is traded under the symbol<br />
BOL on the New York Stock Exchange. Options on the company’s<br />
common stock are traded on the American Stock Exchange.<br />
Trademarks:<br />
The trademarks of <strong>Bausch</strong> & <strong>Lomb</strong> Incorporated and its subsidiary<br />
companies referred to in this report are:<br />
Aberrometer<br />
Alrex<br />
AMVISC<br />
AMVISC Plus<br />
<strong>Bausch</strong> & <strong>Lomb</strong><br />
Boston<br />
Boston EO<br />
Catarex<br />
Hansatome<br />
Design: Richard Uccello, Andrew Wessels<br />
Ted Bertz Graphic Design<br />
Middletown, Connecticut<br />
Printing: Finlay Brothers Printing<br />
Bloomfield, Connecticut<br />
Executive Portrait: Ted Kawalerski<br />
New York, New York<br />
©2000 <strong>Bausch</strong> & <strong>Lomb</strong> Incorporated<br />
All Rights Reserved Worldwide<br />
Medalist<br />
Millennium<br />
MPORT<br />
MPORT SI<br />
Ocuvite<br />
Ocuvite Extra<br />
Opcon-A<br />
Orbscan<br />
Orbscan II<br />
Passport<br />
PureVision<br />
ReNu<br />
ReNu MultiPlus<br />
SofLens<br />
SofLens66<br />
Soflex<br />
Technolas 217<br />
Vitrasert<br />
EVA is a trademark of Stern Stewart & Co.<br />
Lotemax is a trademark of Pharmos Corporation<br />
Polytrim is a trademark of Allergan, Inc.<br />
Surodex is a trademark of Oculex Pharmaceuticals, Inc.